These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7181471)

  • 1. Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1982 Oct; 22(4):560-3. PubMed ID: 7181471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
    Yokota Y; Murakawa T; Nishida M
    J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
    Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
    Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Jan; 33(1):44-8. PubMed ID: 7378171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
    Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolates.
    Malott RJ; Wu CH; Lee TD; Hird TJ; Dalleska NF; Zlosnik JE; Newman DK; Speert DP
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5211-9. PubMed ID: 24957830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines.
    Greenwood D; Edwards R; Brown J; Ridout P
    Infection; 1992; 20 Suppl 4():S302-4. PubMed ID: 1294522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves.
    Flamm RK; Rhomberg PR; Lindley JM; Sweeney K; Ellis-Grosse EJ; Shortridge D
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP; Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents.
    Vanhoof R; Hubrechts JM; Roebben E; Claeys M; Nyssen HJ
    J Antimicrob Chemother; 1986 Mar; 17(3):297-302. PubMed ID: 3457785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
    Baltimore RS; Klein JO; Wilcox C; Finland M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):511-8. PubMed ID: 791104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
    Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
    J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins.
    Blackwell CC; Freimer EH; Tuke GC
    Antimicrob Agents Chemother; 1976 Aug; 10(2):288-92. PubMed ID: 984771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.